Cite
MLA Citation
Meng Xiu et al.. “Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis.” International journal of cancer, vol. 151, no. 4, 2022, pp. 578–589. http://access.bl.uk/ark:/81055/vdc_100158007113.0x00005b